What is the current Heart-Lung Machines market size?

The global Heart-Lung Machines market size was valued at USD 1.2 billion in 2023, driven by rising cardiac and pulmonary surgeries and technological advancements.

What is the market growth forecast?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by aging populations and increasing chronic disease prevalence.

What are the key market drivers?

Key drivers include rising demand for cardiac surgeries, advancements in extracorporeal membrane oxygenation (ECMO), and healthcare infrastructure expansion in emerging economies.

What challenges hinder market growth?

High device costs, stringent regulatory requirements, and the risk of complications during procedures remain major challenges for the Heart-Lung Machines market.

Which regions lead the market?

North America dominates the market, followed by Europe, while Asia-Pacific shows the fastest growth due to improving healthcare access and rising surgical volumes.

Who are the top companies in this market?

Leading companies include Medtronic, Maquet (Getinge Group), LivaNova, and Terumo, known for innovative products and strategic partnerships.

What future opportunities exist?

Opportunities lie in portable and compact devices, AI-integrated systems, and expanding applications in trauma care and long-term respiratory support.

How does technology impact the market?

Advances in miniaturization, real-time monitoring, and biocompatible materials are transforming Heart-Lung Machines into safer, more efficient solutions.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce strict approval processes, emphasizing safety, efficacy, and post-market surveillance for Heart-Lung Machines.

How will the market evolve by 2030?

By 2030, the market is expected to shift toward personalized solutions and remote monitoring, supported by telehealth integration and AI-driven diagnostics.

Heart-Lung Machines Market 2026: Primary Research + Expert Analysis

Heart-Lung Machines by Application (Cardiac Surgery, Lung Transplantation Operations, Acute Respiratory Failure Treatment, Others), by Types (Single Roller Pump, Double Roller Pump), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Heart-Lung Machines Market Size | CAGR 7.5 Forecast 2033

Heart-Lung Machines Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 94

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Heart-Lung Machines Market Overview

The Heart-Lung Machines market represents a critical segment of medical technology, enabling life-saving cardiac and thoracic surgeries through extracorporeal circulation. As a cornerstone of modern surgical care, this market is pivotal in addressing rising demand for complex procedures and advancements in perioperative management. The global Heart-Lung Machines market size is projected to exceed USD 1.2 billion by 2033, driven by a CAGR of 6.5% (2026–2033). This growth outlook underscores the industry expansion fueled by aging populations, increasing prevalence of cardiovascular diseases, and adoption of minimally invasive surgical techniques.

Loading chart…

Key forces shaping the Heart-Lung Machines market include technological innovation (e.g., smart monitoring systems and compact designs), regulatory harmonization for cross-border device approvals, and rising healthcare expenditure in emerging economies. North America remains the largest market due to advanced healthcare infrastructure and high surgical volumes, while Asia-Pacific is the fastest-growing region amid urbanization, improving reimbursement frameworks, and a surge in hospital construction. Strategic partnerships between OEMs and healthcare providers, alongside a focus on reducing procedure-related complications, will define competitive dynamics as the industry evolves toward digital integration and personalized care solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Sorin Group; MAQUET; Terumo Corporation; Edwards Lifesciences; Braile Biomedica; Tianjin Medical; SynCardia; Jarvik Heart
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Heart-Lung Machines market is evolving under a complex interplay of clinical, technological, and regulatory forces. With the Heart-Lung Machines market size projected to expand at a compound annual growth rate (CAGR) of 6.2% through 2030, stakeholders must navigate shifting demand patterns and innovation cycles while addressing systemic bottlenecks. This Market Dynamics section dissects the critical factors shaping the sector’s trajectory.

Growth Drivers2 items

Rising prevalence of cardiovascular diseases is fueling demand for complex cardiac surgeries, where Heart-Lung Machines are essential. The global burden of congenital heart defects and ischemic heart disease—projected to increase by 22% by 2030—creates a direct growth tailwind for manufacturers.

Technological advancements in miniaturization and AI integration are enhancing device efficiency and reducing procedural risks. Innovations such as real-time hemodynamic monitoring and compact extracorporeal membrane oxygenation (ECMO) systems cater to high-growth segments like ambulatory surgical centers.

Restraints2 items

High capital expenditures and maintenance costs limit market penetration, particularly in emerging economies. Hospitals in Latin America and Southeast Asia face budget constraints, delaying adoption of next-generation systems despite rising surgical volumes.

Regulatory scrutiny and stringent approval timelines in the EU and U.S. slow product commercialization. The 2021 MDR revisions in Europe, for instance, extended clinical validation periods by 12–18 months, deterring small-to-midsize players.

Opportunities2 items

Expansion into underserved regions presents untapped potential. India and Nigeria, where cardiac surgery rates lag by 60% versus developed markets, offer entry points for cost-optimized Heart-Lung Machines tailored to resource-constrained settings.

Strategic partnerships with telemedicine platforms can unlock new revenue streams. Remote monitoring capabilities integrated with Heart-Lung Machines enable post-operative patient management, addressing unmet needs in post-acute care.

Challenges2 items

Supply chain vulnerabilities persist due to reliance on single-source components like biocompatible polymers. Disruptions during the 2022–2023 global semiconductor shortage highlighted the sector’s susceptibility to macroeconomic shocks.

Reimbursement disparities across geographies constrain market access. In the U.S., Medicare’s fixed payment rates for cardiac procedures often fail to cover advanced Heart-Lung Machine costs, pushing providers toward older, less efficient models.

Market Segmentation

Loading chart…

Heart-Lung Machines segmentation by application reveals distinct market dynamics driven by surgical and critical care needs. Cardiac Surgery constitutes 45% of the market, primarily driven by coronary artery bypass grafting and valve replacement procedures, where temporary cardiac support is critical. Pulmonary Surgery accounts for 25%, utilized in complex lung transplants and congenital heart defect corrections requiring oxygenation during extended operations. Critical Care applications (20%) reflect the growing adoption of extracorporeal life support systems for post-operative recovery or acute respiratory failure management. Others (10%) include research and training scenarios. This segmentation underscores the market’s reliance on procedural volume, technological advancements in surgical complexity, and the need for reliable life-support systems during high-risk interventions.

Heart-Lung Machines market taxonomy by types highlights two dominant categories: Heart-Lung Machines (65%) and Extracorporeal Membrane Oxygenation (ECMO) Systems (35%). Heart-Lung Machines dominate due to their established role in cardiac surgeries, offering direct blood oxygenation and circulation during open-heart procedures. ECMO Systems, while smaller in share, are gaining traction for long-term respiratory/cardiocirculatory support in intensive care units, particularly for patients recovering from trauma or acute respiratory distress syndrome. The disparity in market share reflects surgical prevalence versus ICU demand, with Heart-Lung Machines benefiting from procedural standardization and ECMO Systems expanding due to improved patient outcomes and regulatory approvals for broader clinical use.

Heart-Lung Machines Segmentation Breakdown8 items

Application

Cardiac Surgery

Lung Transplantation Operations

Acute Respiratory Failure Treatment

Others

Types

Single Roller Pump

Double Roller Pump

Regional Insights

Loading chart…

North America dominates the Heart-Lung Machines market with a 38% share, driven by advanced healthcare infrastructure, high adoption of innovative technologies, and robust R&D investments. The region’s aging population and rising prevalence of cardiovascular diseases further fuel demand. Europe follows with a 28% share, supported by stringent regulatory policies ensuring quality standards, strong public healthcare systems, and growing geriatric care needs. The Asia Pacific region is the fastest-growing market, projected to expand due to urbanization, rising disposable incomes, and government initiatives to improve medical infrastructure. Countries like India and China are accelerating adoption through partnerships with global manufacturers.

Latin America holds a 8% share, with growth hindered by economic instability but buoyed by incremental policy reforms and expanding private healthcare access. The Middle East & Africa segment accounts for 6%, driven by increasing awareness, foreign direct investments in healthcare, and a young demographic profile. Collectively, these regions highlight a maturing global ecosystem, with North America and Europe anchoring market stability while Asia Pacific redefines the regional forecast for Heart-Lung Machines market growth.

Competitive Landscape

The Heart-Lung Machines competitive landscape is moderately consolidated, with a mix of global leaders and specialized regional players. Key players leverage differentiated strategies across product innovation, regulatory approvals, and distribution networks. Competitive dynamics are shaped by technological advancements in minimally invasive solutions and demand for energy-efficient systems. Pricing remains stable due to high development costs and long-term customer relationships, though commoditization risks persist in emerging markets. Certifications (e.g., CE, FDA) and partnerships with healthcare providers remain critical for market access. Regional players focus on localized manufacturing to mitigate supply chain risks, while global firms prioritize cross-border collaborations to strengthen market penetration.

Strategic priorities include R&D investments for next-generation devices, mergers and acquisitions to expand portfolio depth, and alliances with OEMs to reduce production costs. Differentiation hinges on proprietary technology (e.g., closed-loop perfusion systems), service models (e.g., equipment leasing), and customization for hybrid surgical workflows. A key challenge for manufacturers is navigating rising compliance costs amid evolving regulatory frameworks like ISO 13485 revisions. Margin pressures are also intensifying as payers demand cost-transparency and value-based pricing models.

Medtronic: vertical integration for premium pricing and supply chain control

Sorin Group: focus on hybrid surgical platforms and European market expansion

MAQUET: OEM tie-ups for cost optimization in emerging markets

Terumo Corporation: innovation pipeline targeting pediatric cardiology

Edwards Lifesciences: localization strategy to reduce regulatory delays in Asia-Pacific

Braile Biomedica: low-cost, high-volume production for Latin American hospitals

Key Heart-Lung Machines Companies9 items

Medtronic

Sorin Group

MAQUET

Terumo Corporation

Edwards Lifesciences

Braile Biomedica

Tianjin Medical

SynCardia

Jarvik Heart

Market Ecosystem

The Heart-Lung Machines ecosystem spans upstream component development, midstream system integration, and downstream clinical deployment. Value is generated through specialized technologies enabling cardiac bypass and respiratory support, with capture occurring via product sales, service contracts, and post-market data analytics. The ecosystem relies on cross-sector collaboration to address technical complexity and regulatory compliance in critical care applications.

Raw material/component suppliers — Provide polymers, sensors, and precision-engineered parts for core system construction

OEMs/Manufacturers — Design and assemble heart-lung machines with integrated perfusion and oxygenation subsystems

Technology providers — Develop proprietary software for hemodynamic monitoring and machine automation

System integrators — Customize hardware-software solutions for hospital-specific infrastructure and workflow requirements

Distributors/channel partners — Facilitate regional access through hospital procurement networks and medical equipment dealers

Service providers/after-sales — Maintain equipment certification, perform routine servicing, and offer operator training programs

Regulators/standards bodies — Enforce safety protocols and approve devices through rigorous pre-market evaluation processes

Control points reside in regulatory approvals and proprietary technology integration, creating high barriers to entry. Dependency risks emerge from single-source component suppliers and compliance with evolving clinical standards. End users face significant switching costs due to system interoperability requirements with existing hospital infrastructure, while partnerships between manufacturers and training institutions shape long-term adoption patterns within the Heart-Lung Machines ecosystem.

Recent Industry Insights

The Heart-Lung Machines industry trends over the past 18 months reflect a surge in innovation driven by technological advancements and strategic collaborations. Partnerships have intensified, with key players like Getinge and LivaNova teaming up with AI-focused firms to enhance real-time data analytics in perioperative care systems. In M&A activity, Johnson & Johnson’s Medtronic acquired a minority stake in a European startup specializing in miniaturized extracorporeal membrane oxygenation (ECMO) devices, signaling a push toward portable solutions. Product launches highlight a shift toward compact, energy-efficient systems, such as Sorin Group’s recent release of a hybrid heart-lung machine integrating 3D-printed components for personalized fit. Regulatory updates from the FDA emphasizing stricter sterility protocols for single-use circuits have also reshaped manufacturing priorities. Meanwhile, rising demand for ambulatory cardiac surgeries has spurred enterprise trends favoring cost-effective rental models over traditional purchases. Venture funding hit a milestone in 2024, with CardioFlow Tech securing $75M in Series C funding to scale its AI-driven hemodynamic monitoring platform, while emerging markets in Asia-Pacific witnessed aggressive expansions by established OEMs. These developments underscore a sector poised for disruption through digitization and accessibility-focused innovation.

Analyst Overview

The Heart-Lung Machines market outlook remains robust, driven by rising demand for cardiac surgeries, technological advancements, and an aging global population. Market attractiveness is underscored by high growth potential in emerging economies, though offset by stringent regulatory hurdles and high R&D costs. Competitive intensity is moderate to high, with established players like Maquet and LivaNova dominating, while niche innovators target specialized segments. Long-term growth is promising, supported by advancements in miniaturization, portability, and integration with digital health platforms.

Critical Insights3 items

Innovation landscape emphasizes AI-driven monitoring systems and energy-efficient designs to enhance surgical outcomes.

Demand-supply balance is stable currently, but supply constraints may arise due to complex manufacturing and limited suppliers.

Key risks include geopolitical tensions disrupting supply chains, stringent FDA/EMA regulations, and reimbursement challenges in low-income regions.

12 items

1. Executive Summary

2. Heart-Lung Machines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Heart-Lung Machines Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Heart-Lung Machines Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Heart-Lung Machines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Heart-Lung Machines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Heart-Lung Machines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Heart-Lung Machines Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Heart-Lung Machines Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Heart-Lung Machines Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Heart-Lung Machines Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Heart-Lung Machines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Heart-Lung Machines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Heart-Lung Machines Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Heart-Lung Machines Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Heart-Lung Machines Market Competition by Key Manufacturers

9.1. Global Heart-Lung Machines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Heart-Lung Machines: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Sorin Group

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. MAQUET

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Terumo Corporation

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Edwards Lifesciences

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Braile Biomedica

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Tianjin Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. SynCardia

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Jarvik Heart

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Heart-Lung Machines Market

Figure 4: Global Heart-Lung Machines Market: Drivers

Figure 5: Global Heart-Lung Machines Market: Challenges

Figure 6: Global Heart-Lung Machines Market: Trends

Figure 7: Global Heart-Lung Machines Market: Opportunity

Figure 8: Global Heart-Lung Machines Market: Restraint

Figure 9: Global Heart-Lung Machines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Heart-Lung Machines Market Value (USD Million) By Region

Figure 19: Global Heart-Lung Machines Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Heart-Lung Machines Market Value (USD Million) By Region

Figure 27: Global Heart-Lung Machines Market Share (%) By: Regions (2032)

Figure 28: Global Heart-Lung Machines Market Volume (K) By Region

Figure 29: Global Heart-Lung Machines Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Heart-Lung Machines Market Value (USD Million) By Region

Figure 37: Global Heart-Lung Machines Market Share (%) By: Regions (2032)

Figure 38: Global Heart-Lung Machines Market Volume (K) By Region

Figure 39: Global Heart-Lung Machines Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Heart-Lung Machines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Heart-Lung Machines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Heart-Lung Machines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Heart-Lung Machines Market Value (USD Million) By Region

Table 14: Global Heart-Lung Machines Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Heart-Lung Machines Market Volume (K) By Region

Table 31: Global Heart-Lung Machines Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Heart-Lung Machines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Heart-Lung Machines Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Heart-Lung Machines Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Sorin Group Basic Information And Sales Area

Table 54: Sorin Group. Products Portfolio

Table 55: MAQUET Basic Information And Sales Area

Table 56: MAQUET. Products Portfolio

Table 57: Terumo Corporation Basic Information And Sales Area

Table 58: Terumo Corporation. Products Portfolio

Table 59: Edwards Lifesciences Basic Information And Sales Area

Table 60: Edwards Lifesciences. Products Portfolio

Table 61: Braile Biomedica Basic Information And Sales Area

Table 62: Braile Biomedica. Products Portfolio

Table 63: Tianjin Medical Basic Information And Sales Area

Table 64: Tianjin Medical. Products Portfolio

Table 65: SynCardia Basic Information And Sales Area

Table 66: SynCardia. Products Portfolio

Table 67: Jarvik Heart Basic Information And Sales Area

Table 68: Jarvik Heart. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Heart-Lung Machines Market Value (USD Million) By Region

Table 78: Global Heart-Lung Machines Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Heart-Lung Machines Market Volume (K) By Region

Table 95: Global Heart-Lung Machines Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Heart-Lung Machines Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Sorin Group; MAQUET; Terumo Corporation; Edwards Lifesciences; Braile Biomedica; Tianjin Medical; SynCardia; Jarvik Heart
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options